Abstract
This study examines the extent to which managed care behavioral controls are associated with treatment intensity in outpatient substance abuse treatment facilities. Data are from the 1995 National Drug Abuse Treatment System Survey, a nationally representative survey that includes over 600 provider organizations with a response rate of 86%. Treatment intensity is measured in three ways: (1) the number of months clients spend in outpatient drug treatment, (2) the number of individual treatment sessions clients receive over the course of treatment, and (3) the number of group treatment sessions clients receive over the course of treatment. After accounting for selection bias and controlling for market, organization, and client characteristics, there is no significant relationship between the scope of managed care oversight and treatment intensity. However, the stringency of managed care oversight activities is negatively associated with the number of individual and group treatment sessions received over the course of treatment.
Similar content being viewed by others
References
Mechanic D, Schlesinger M, McAlpine DD. Management of mental health and substance abuse services: state of the art and early results.The Milbank Quarterly. 1995;73(1):19–55.
Wells KB, Astrachan BM, Tischler GL, et al. Issues and approaches in evaluating managed mental health care.The Milbank Quarterly. 1995;73(1):57–75.
Findlay S. Managed behavioral health care in 1999: an industry at a crossroads.Health Affairs. 1999;18(5):116–124.
Manderscheid RW, Henderson MJ.Speaking with a Common Language: The Past, Present and Future of Data Standards for Managed Behavioral Healthcare. Rockville, MD: Center for Mental Health Services, Division of State and Community Systems Development; 1995.
Mechanic D, McAlpine DD. Mission unfulfilled: potholes on the road to mental health parity.Health Affairs. 1999;18(5):7–21.
McLellan AT, Woody GE, Metzger D, et al. Evaluating the effectiveness of addiction treatment: reasonable expectations, appropriate comparisons. In: Egerton JA, Fox DM, Leshner AI, eds.Treating Drug Abusers Effectively. Malden, MA: Blackwell; 1997.
Bell DC, Richard AJ, Feltz LC. Mediators of drug treatment outcomes.Addictive Behaviors. 1996;21(5):597–613.
Ershoff D, Radcliffe A, Gregory M. The southern California Kaiser-Permanente chemical dependency recovery program evaluation: results of a treatment outcome study in an HMO setting.Journal of Addictive Diseases. 1996;15(3):1–25.
Hoffmann NG, Miller NS. Treatment outcomes for abstinence-based programs.Psychiatric Annals. 1992;22(8):402–408.
Hubbard RL, Marsden ME, Rachal JV.Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: University of North Carolina Press; 1989.
McKay JR, Alterman AI, McLellan AT, et al. Treatment goals, continuity of care and outcomes in a day hospital substance abuse rehabilitation program.American Journal of Psychiatry. 1994;151(2):254–259.
Moos RH, Finney JW, Cronkite RC.Alcoholism Treatment: Content, Process, and Outcome. New York: Oxford University Press; 1990.
Simpson DD. Effectiveness of drug-abuse treatment: a review of research from field settings. In: Egerton JA, Fox DM, Leshner AI, eds.Treating Drug Abuse Effectively. Malden, MA: Blackwell Publishers; 1997.
Campbell J, Gabrielli W, Laster LJ, et al. Efficacy of outpatient intensive treatment for drug abuse.Journal of Addictive Diseases. 1997;16(2):15–25.
Higgins ST, Budney AJ, Bickel WK, et al. Participation of significant others in outpatient behavioral treatment predicts greater cocaine abstinence.American Journal of Drug and Alcohol Abuse. 1993;20(1):47–56.
Hoffman JA, Caudill BD, Koman JJ III, et al. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure.Journal of Addictive Diseases. 1994;13(4):115–128.
Kang S, Kleinman PH, Woody GE. Outcomes for cocaine abusers after once-a-week psychosocial therapy.The American Journal of Psychiatry. 1991;148:630–635.
Simpson DD, Joe GW, Rowan-Szal G, et al. Client engagement and change during drug abuse treatment.Journal of Substance Abuse. 1995;7(1):117–134.
Edmunds M, Frank R, Hogan M, et al., eds.Managing Managed Care: Quality Improvements in Behavioral Health. Washington, DC: National Academy Press; 1997.
Beinecke RH, Goodman M, Lockhart A. The impact of managed care on Massachusetts mental health and substance abuse providers.Administration in Social Work. 1997;21(2):41–53.
French MT, Dunlap LJ, Galinis BA, et al. Health care reforms and managed care for substance abuse services: findings from eleven case studies.Journal of Public Health Policy. 1996;17(2):181–203.
Miller WR. The effectiveness of treatment for substance abuse: reasons for optimism.Journal of Substance Abuse Treatment. 1992;9:93–102.
Alexander JA, Lemak CH. Managed care penetration in outpatient substance abuse treatment units.Medical Care Research and Review. 1997;54(4):490–507.
Alexander JA, Lemak CH. Directors' perceptions of the effects of managed care on outpatient substance abuse treatment.Journal of Substance Abuse. 1997;9:1–14.
Alexander JA, Lemak CH. The effects of managed care on administrative burden in outpatient substance abuse treatment facilities.Medical Care. 1997;35(10):1060–1068.
Alexander JA, Wheeler JRC, Nahra T, et al. Managed care and technical efficiency in outpatient substance abuse treatment units.Journal of Behavioral Health Services and Research. 1998;25(4):377–396.
Substance Abuse and Mental Health Services Administration.Overview of the National Drug and Alcohol Treatment Unit Survey (NDATUS): 1992 and 1980–1992. Advance Report No. 9. Rockville, MD: Author; 1995.
Pfeffer J, Salancik G.The External Control of Organizations: A Resource Dependence Perspective. New York: Harper & Row; 1978.
Hasenfeld YE.The Organization of Human Services: Structure and Processes. Beverly Hills, CA: Sage; 1992.
D'Aunno T, Sutton RI, Price RH. Isomorphism and external support in conflicting institutional environments: a study of drug abuse treatment units.Academy of Management Journal. 1991;34(3):636–661.
Flynn DM. Sponsorship and the survival of new organizations.Journal of Small Business Management. January 1993:51–62.
Oliver C. Strategic responses to institutional processes.Academy of Management Review. 1991;16(1):145–179.
Wheeler JRC, Fadel H, D'Aunno TA. Ownership and performance of outpatient substance abuse treatment centers.American Journal of Public Health. 1992;82(5):711–718.
Etheridge R, Hubbard RL, Anderson J, et al. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS).Psychology of Addictive Behaviors. 1997;11(4):244–260.
Simpson DD, Savage LJ, Lloyd MR. Follow-up evaluation of treatment of drug abuse during 1969 to 1972.Archives of General Psychiatry. 1979;36:772–780.
Simpson DD. Treatment for drug abuse: follow-up outcomes and length of time spent.Archives of General Psychiatry. 1981;38:875–880.
Alemi F, Stephens RC, Llorens S, et al. A review of factors affecting treatment outcomes: expected treatment outcome scale.American Journal of Drug and Alcohol Abuse. 1995;21(4):483–509.
Joe GW, Simpson DD, Sells SB. Treatment process and relapse to opioid use during methadone maintenance.American Journal of Drug and Alcohol Abuse. 1992;19:124–130.
McLellan AT, Alterman AI, Metzger DS, et al.. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services.Journal of Consulting and Clinical Psychology. 1994;62(6):1141–1158.
Ornstein P, Cherapon JA. Demographic variables as predictors of alcoholism treatment outcome.Journal of Studies on Alcohol. 1985;46(5):425–432.
Groves RL.Telephone Survey Methodology. New York: Wiley; 1988.
D'Aunno T, Vaughn TE, McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient substance abuse treatment units.Journal of Health and Social Behavior. 1999;40:175–192.
Batten HL, Prottas JM, Horgan CM, et al, eds.Drug Services Research Survey, Final Report: Phase II. Waltham, MA: Institute for Health Policy, Brandeis University; 1992.
Shwartz M, Mulvey KP, Woods D, et al. Length of stay as an outcome in an era of managed care: an empirical study.Journal of Substance Abuse Treatment. 1997;14(1):11–18.
Heckman JJ. Sample selection bias as a specification error.Econometrica. 1979;47:153–161.
Breen R.Regression Models: Censored, Sample-Selected, or Truncated Data. Thousand Oaks, CA: Sage; 1996.
Lemak CH, Alexander JA, D'Aunno TA. Organizational analysis of selective contracting in managed care: the case of substance abuse treatment. Working paper, 1999.
Goldman W, McCulloch J, Cuffel B, et al. More evidence for the insurability of managed behavioral health care.Health Affairs. 1999;18(5):172–181.
Nurco DN, Kinlock TW, Hanlon TE. The nature and status of drug abuse treatment.Maryland Medical Journal. 1994;43(1):51–57.
Wheeler JRC, Nahra TA. Private and public ownership in behavioral health care: do we have a two-tiered system?Administration and Policy in Mental Health. 2000;27(4):197–209.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lemak, C.H., Alexander, J.A. Managed care and outpatient substance abuse treatment intensity. The Journal of Behavioral Health Services & Research 28, 12–29 (2001). https://doi.org/10.1007/BF02287231
Issue Date:
DOI: https://doi.org/10.1007/BF02287231